摘要
目的探讨Hcy,HbA1c以及Hs-CRP联合检测对2型糖尿病早期肾损伤筛查的价值.方法抽样时间段为2019年1月-2020年1月,抽样对象为在我院接受体检的2型糖尿病早期肾损伤患者,和同期体检的健康者,抽样数量为160例,研究方法为:先使用分组研究法,将160例体检者分为对照组和研究组,其中对照组为健康体检者80例,研究组为确诊的2型糖尿病早期肾损伤患者80例,分组完毕后再对两组体检者分别实施Hcy,HbA1c以及Hs-CRP联合检测,对比对照组和研究组两组检测结果的差异,来探讨Hcy、HbA1c以及Hs-CRP联合检测的价值.结果经检测,研究组患者三项检测指标均高于对照组,同时从检测阳性率方面看,联合检测阳性率低于单独检测,数据对比差异明显,有统计学意义(P<0.05).结论Hcy、HbA1c以及Hs-CRP联合检测可作为2型糖尿病早期肾损伤的检测指标,能够准确判断患者的肾损伤情况,为后续治疗提供保证.
Objective To explore the value of combined detection of Hcy,HbA1c and hs CRP in screening early renal injury in type 2 diabetes.Methods The sampling period was from January 2019 to January 2020.The sampling objects were the patients with early renal injury of type 2 diabetes who underwent physical examination in our hospital and the healthy people who underwent physical examination at the same time.The sampling number was 160.The research method was:first,using the grouping research method,160 physical examiners were divided into the control group and the research group,of which 80 were healthy physical examiners and 80 were diagnosed as early renal injury of type 2 diabetes,After grouping,Hcy,HbA1c and hs CRP were jointly detected in the two groups of physical examinees,and the difference between the test results of the control group and the study group was compared to explore the value of the combined detection of Hcy,HbA1c and hs CRP.Results After the test,the three test indexes of the study group were higher than those of the control group.At the same time,the positive rate of the combined test was lower than that of the single test in terms of the positive rate of the test.The data comparison difference was significant(P<0.05).Conclusion The combined detection of Hcy,HbA1c and hs CRP can be used as the detection index of early renal injury in patients with type 2 diabetes,and can accurately judge the renal injury of patients and provide guarantee for follow-up treatment.
作者
朱晓霞
ZHU Xiao-xia(PKUCare CNOOC Hospital,Tianjin 300450,China)
出处
《医学信息》
2022年第S01期91-93,共3页
Journal of Medical Information
